Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy

BACKGROUND: The risk for radiation necrosis is lower in fractionated stereotactic radiotherapy (SRT) than in conventional radiotherapy, and 13-fraction SRT is our method of choice for the treatment of brain metastases ≥ around 2 cm or patients who are expected to have a good prognosis. As 13-fractio...

Descripción completa

Detalles Bibliográficos
Autores principales: Uto, Megumi, Ogura, Kengo, Katagiri, Tomohiro, Takehana, Keiichi, Mizowaki, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317405/
https://www.ncbi.nlm.nih.gov/pubmed/34321033
http://dx.doi.org/10.1186/s13014-021-01869-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317405/
https://www.ncbi.nlm.nih.gov/pubmed/34321033
http://dx.doi.org/10.1186/s13014-021-01869-4

Ejemplares similares